Orphan Medical, Kirin Brewery Co. Ltd sales and marketing update

Kirin received exclusive rights to market ORPH's Busulfex busulfan conditioning regimen for patients receiving bone marrow and stem cell transplants, in Japan, China, South Korea, and Taiwan. Kirin w...